Differential diagnosis of suspected multiple sclerosis: an updated consensus approach

AJ Solomon, G Arrambide, WJ Brownlee… - The Lancet …, 2023 - thelancet.com
Accurate diagnosis of multiple sclerosis requires careful attention to its differential diagnosis—
many disorders can mimic the clinical manifestations and paraclinical findings of this …

Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective

M Filippi, P Preziosa, DL Arnold, F Barkhof… - Journal of …, 2023 - Springer
In recent years, the use of magnetic resonance imaging (MRI) for the diagnostic work-up of
multiple sclerosis (MS) has evolved considerably. The 2017 McDonald criteria show high …

Diagnostic performance of cortical lesions and the central vein sign in multiple sclerosis

A Cagol, R Cortese, M Barakovic, S Schaedelin… - JAMA …, 2024 - jamanetwork.com
Importance Multiple sclerosis (MS) misdiagnosis remains an important issue in clinical
practice. Objective To quantify the performance of cortical lesions (CLs) and central vein …

What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?

MS Martire, L Moiola, MA Rocca, M Filippi… - Expert review of …, 2022 - Taylor & Francis
Introduction In multiple sclerosis (MS), paramagnetic rim lesions (PRLs) on MRI identify a
subset of chronic active lesions (CALs), which have been linked through clinical and …

Emerging imaging and liquid biomarkers in multiple sclerosis

AJ Gill, EM Schorr, SP Gadani… - European Journal of …, 2023 - Wiley Online Library
The advent of highly effective disease modifying therapy has transformed the landscape of
multiple sclerosis (MS) care over the last two decades. However, there remains a critical …

[HTML][HTML] Cortical lesions, central vein sign, and paramagnetic rim lesions in multiple sclerosis: Emerging machine learning techniques and future avenues

F La Rosa, M Wynen, O Al-Louzi, ES Beck… - NeuroImage: Clinical, 2022 - Elsevier
The current diagnostic criteria for multiple sclerosis (MS) lack specificity, and this may lead to
misdiagnosis, which remains an issue in present-day clinical practice. In addition …

Neurodegeneration in multiple sclerosis

GM Mey, KR Mahajan… - WIREs mechanisms of …, 2023 - Wiley Online Library
Axonal loss in multiple sclerosis (MS) is a key component of disease progression and
permanent neurologic disability. MS is a heterogeneous demyelinating and …

[HTML][HTML] From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions

H Kolb, O Al-Louzi, ES Beck, P Sati, M Absinta… - NeuroImage: Clinical, 2022 - Elsevier
Focal lesions in both white and gray matter are characteristic of multiple sclerosis (MS).
Histopathological studies have helped define the main underlying pathological processes …

Multiple sclerosis diagnostic delay and misdiagnosis

M Kaisey, AJ Solomon - Neurologic Clinics, 2024 - neurologic.theclinics.com
Accurate interpretation of a patient's clinical presentation and radiologic studies,
accompanied by knowledgeable and thoughtful application of the 2017 revised McDonald …

Recent advances in diagnostic, prognostic, and disease-monitoring biomarkers in multiple sclerosis

A Chertcoff, R Schneider, CJ Azevedo… - Neurologic …, 2024 - neurologic.theclinics.com
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the
central nervous system (CNS) and the leading progressive neurologic condition a Division …